Page 28 - மேற்கு கனெக்டிகட் நிலை பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer VP: Vaccine can be adapted to fight COVID variants FacebookTwitterEmail 1of3 Carly Plymel, RN, preps a dose of the Pfizer COVID-19 vaccine at the Stamford Health Vaccination Super Site April 6.Tyler Sizemore / Hearst Connecticut MediaShow MoreShow Less 2of3 Morten Sogaard, vice president of Target Sciences, Emerging Science & Innovation, at Pfizer Worldwide R&DContributed /Western Connecticut State UniversityShow MoreShow Less 3of3 As new strains of the virus that cause COVID-19 are circulating around the U.S., a Pfizer executive said Saturday that the company’s vaccine could be quickly adapted to fight the new strains. Morten Sogaard, vice president of Target Sciences, Emerging Science & Innovation, noted the company’s mRNA vaccine has an advantage because Pfizer can “alter the sequence of the RNA very easily.”

Saudi arabiaUnited statesAlbert bourlaConnecticut state universityYale school of public healthJackson laboratoryWestern connecticut state universityNed lamontYale schoolPublic healthMorten sogaardNed lamontMerging science ampAlbert bourlaSaudi arabiaWestern connecticut state university